Hunter Gillies is CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE). They have made 1 open-market trade across 1 company since 2023, most recently 2024-06-13.
CIK 0001868997
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVTE | 11,602 | $31K |
Shares reported on the most recent Form 4, priced at the 2024-06-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTE | SELL · 10b5-1 | 2024-06-13 | 2024-06-14 | $24.50 | $147K | -30.7% | -21.2% | -22.0% |
| AVTE | SELL · 10b5-1 | 2024-05-17 | 2024-05-17 | $21.08 | $167K | -13.3% | -91.9% | -91.2% |
| AVTE | SELL · 10b5-1 | 2024-04-17 | 2024-04-19 | $22.34 | $172K | -5.7% | -8.7% | -91.8% |
| AVTE | SELL · 10b5-1 | 2024-03-28 | 2024-04-01 | $29.50 | $266K | -7.8% | -28.5% | -94.2% |
| AVTE | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $25.84 | $346K | +12.9% | -15.8% | -94.6% |
| AVTE | SELL · 10b5-1 | 2024-03-07 | 2024-03-11 | $24.50 | $440K | +5.4% | +9.5% | -11.4% |
| AVTE | SELL · 10b5-1 | 2024-02-23 | 2024-02-27 | $19.50 | $10K | +13.2% | +26.2% | -31.4% |
| AVTE | SELL · 10b5-1 | 2024-02-20 | 2024-02-22 | $20.18 | $123K | +21.5% | +43.3% | -4.3% |
| AVTE | SELL · 10b5-1 | 2024-01-17 | 2024-01-19 | $19.50 | $78K | -4.5% | -7.0% | +6.9% |
| AVTE | SELL · 10b5-1 | 2023-12-27 | 2023-12-29 | $24.50 | $3K | -8.4% | -19.6% | +31.4% |
| AVTE | SELL · 10b5-1 | 2023-12-20 | 2023-12-22 | $19.50 | $78K | -7.6% | -5.7% | +22.5% |
| AVTE | SELL · 10b5-1 | 2023-12-13 | 2023-12-15 | $19.50 | $427K | +30.9% | +9.3% | +34.9% |
| AVTE | SELL · 10b5-1 | 2023-05-19 | 2023-05-23 | $19.50 | $1K | -8.3% | -7.0% | -16.6% |
| AVTE | SELL · 10b5-1 | 2023-05-17 | 2023-05-19 | $19.59 | $21K | -9.8% | -11.9% | -20.0% |
| AVTE | SELL | 2023-04-21 | 2023-04-25 | $19.50 | $78K | +17.4% | -7.0% | -9.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.